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Review Series: Periostin: From Pathogenesis to Clinical Application in Allergic Diseases
Periostin in Skin Tissue and
Skin-Related Diseases
Yukie Yamaguchi1
ABSTRACT
Extracellular matrix (ECM) is not only involved in the maintenance of normal physiological tissue but also in in-
teractions with other ECM components, tissue remodeling, and modulating immune responses. The skin pro-
vides a distinctive environment characterized by rich fibroblasts producing various ECM proteins, epithelial-
mesenchymal interactions, and immune responses induced by external stimuli.
Recently, periostin―a matricellular protein―has been highlighted for its pivotal functions in the skin. Analy-
sis of periostin null mice has revealed that periostin contributes to collagen fibrillogenesis, collagen cross-
linking, and the formation of ECM meshwork via interactions with other ECM components. Periostin expression
is enhanced by mechanical stress or skin injury; this is indicative of the physiologically protective functions of
periostin, which promotes wound repair by acting on keratinocytes and fibroblasts. Along with its physiological
functions, periostin plays pathogenic roles in skin fibrosis and chronic allergic inflammation. In systemic sclero-
sis (SSc) patients, periostin levels reflect the severity of skin fibrosis. Periostin null mice have shown reduced
skin fibrosis in a bleomycin-induced SSc mouse model, indicating a key role of periostin in fibrosis. Moreover, in
atopic dermatitis (AD), attenuated AD phenotype has been observed in periostin null mice in a house dust mite
extract-induced AD mouse model. Th2 cytokine-induced periostin acts on keratinocytes to produce inflamma-
tory cytokines that further enhance the Th2 response, thereby sustaining and amplifying chronic allergic inflam-
mation. Thus, periostin is deeply involved in the pathogenesis of AD and other inflammation-related disorders
affecting the skin. Understanding the dynamic actions of periostin would be key to dissecting pathogenesis of
skin-related diseases and to developing novel therapeutic strategies.
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INTRODUCTION
The skin is the largest organ of the human body, pro-
viding a protective barrier against external patho-
gensallergens and thermal and physical injuries;
moreover, it plays a role in immunological surveil-
lance and acts as a sensory organ.1,2 The extracellular
matrix (ECM) is a large component of the dermis and
is critical for maintaining normal physiological struc-
ture.3,4 In the dermis, the predominant ECM is colla-
gen; however, other ECMs―such as fibronectin,
laminins, vitronectins, and proteoglycans―are also
present.5 Accumulating evidence has revealed that
the ECM is being continuously remodeled as part of
the normal homeostasis process in response to me-
chanical stimuli, angiogenesis, and wound healing.6,7
Further, ECM interacts with other ECM tissues, im-
mune cells, and vascular cells, thereby regulating cell
proliferation, differentiation and intracellular signal-
ing.7,8 Since ECM remodeling is tightly regulated,
even a small aberration may disturb its balance, trig-
gering the development of diseases. For instance, fi-
brosis, which is essentially the excessive accumula-
tion of ECM, can lead to organ dysfunction.
Periostin is an ECM protein composed of a N-
terminal EMI domain, four repeated fasciclin (Fas I)
domains, and a C-terminal domain with a heparin-
binding site.9,10 Periostin directly binds to type I colla-
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gen11,12 and fibronectin13 via the EMI domain and to
tenascin-C13 via Fas I domains, likely providing ECM
meshwork. Furthermore, as periostin is a matricellu-
lar protein,14,15 secreted periostin directly acts on
various cells as a ligand of integrin receptors to in-
duce cell signaling for proliferation, migration, and
differentiation. Interleukin (IL)-4, IL-13, and trans-
forming growth factor-β (TGF-β) are known as major
triggers of periostin production.11,16 Recent studies
have revealed that periostin is prominently expressed
during tissue development and ECM remodeling un-
der mechanical stress and injury, playing a role in
various pathologies, such as cancers,10,17,18 myocar-
dial infarction,19,20 valvular heart diseases,21,22 fi-
broproliferative disorders,23-26 and chronic allergic in-
flammations.11,27-31
Since the skin consists of rich ECM produced by fi-
broblasts and the immune response occurs there, the
involvement of periostin in skin remodeling and cer-
tain skin-related pathologies has been hypothesized.
In fact, periostin has been demonstrated to play a key
role in collagen fibrillogenesis and wound repair by
analyzing periostin knockout mice.9,12,32-36 Interest-
ingly, recent advances in periostin research have
shown its functional role in the etiology of diseases,
particularly in atopic dermatitis (AD) as a skin-related
allergic disease.30,31 Clarifying the pathogenic proper-
ties of periostin may lead to new therapeutic strate-
gies as well as to novel clinically useful tools, such as
biomarkers.
This review focuses on the physiological roles of
periostin in the context of cutaneous development, re-
generation, and wound repair. Furthermore, it dis-
cusses the pathogenic roles of periostin in skin-
related diseases, including fibroproliferative disor-
ders and allergic diseases. For additional reviews re-
garding the role of periostin in lung- or nose-related
diseases, please see other articles in this issue.37-39
PERIOSTIN EXPRESSION DURING SKIN
DEVELOPMENT AND AGING
Periostin is widely expressed in various organs. From
a gene expression comparison analysis using normal
human tissues, periostin has been shown to be highly
expressed in the skin as compared to that in other or-
gans,40 probably due to the skin being an environ-
ment rich in fibroblasts, which are a major source of
periostin. During embryonic development in murine
skin, expression patterns of periostin vary with time
over the course of development. For instance, peak
periostin deposition is observed uniformly and in-
tensely in both the epidermal-dermal junction (EDJ)
and dermis at embryonic day 17.5, followed by a
gradual decrease, except in hair follicles after birth.33
This suggests that periostin may mediate initial skin
development and may influence the early interactions
of fibroblasts and basal keratinocytes, although the
exact mechanisms by which periostin contributes to
embryonic skin development in vivo remain un-
known.
Typically, periostin is expressed in normal human
skin as a mild deposition at the EDJ, papillary dermis,
and around hair follicles (Fig. 1). A recent study dem-
onstrated that periostin expression is downregulated
during skin aging, which eventually contributes to
the phenotype of aged skin.41 Further, UV irradiation
was shown to reduce periostin expression in dermal
fibroblasts; however, periostin knockdown had no ef-
fect on collagen expression but resulted in aberrant
collagen structures, leading to an increased suscepti-
bility of collagen toward proteases.41 Thus, periostin
is likely to be involved in skin homeostasis and aging,
probably mediated by its functions in collagen assem-
bly, as explained below.
ROLES OF PERIOSTIN IN COLLAGEN FIB-
RILLOGENESIS BASED ON THE SKIN PHE-
NOTYPE OF PERIOSTIN KNOCKOUT MICE
In 2005, Rios et al. first generated periostin null mice
and reported the resulting phenotypes.42 Periostin
deficiency did not exhibit embryonic lethality; how-
ever, periostin null mice were severely growth re-
tarded, indicating that periostin is important in post-
natal development. The periostin null mice showed a
severe periodontal disease-like phenotype with some
defects in the adult periosteum, incisor enamel, carti-
lage, cardiac valves, and periodontal ligament (PDL).
In addition, Kii et al. also suggested that periostin
may be important in the remodeling of the collagen
matrix in the shear zone of the PDL.43 Fundamen-
tally, periostin appears to be required for the mainte-
nance of tissue integrity and protection from me-
chanical stresses in connective tissues.
Subsequently, the skin of periostin null mice was
analyzed in detail by Norris et al..12 The skin was ap-
parently normal; however, they demonstrated a re-
duced diameter of collagen fibrils in the dermis of pe-
riostin null mice, resulting in decreased skin stiff-
ness. Collagen cross-linking was significantly re-
duced in the periostin-deficient mice.12 In agreement
with previous data that showed interactions of pe-
riostin with various ECM proteins,11-13 they reported
the direct binding of periostin to type I collagen.
Thus, periostin was considered to be required for ap-
propriate collagen fibril formation and maturation,
i.e., for collagen fibrillogenesis. Moreover, the ECM-
periostin interaction likely contributes to optimal
biomechanical function in connective tissues such as
the skin, heart valves, bones, tendons, and liga-
ments.12 Collagen fibrillogenesis is the finely regu-
lated process of assembling collagen fibrils wherein
several molecules, such as fibronectin and integrins,
are involved.44 It is likely that matricellular proteins
are essential for collagen fibrillogenesis, since defec-
tive collagen fibrils have also been found in mice with
a gene deficiency for another matricellular protein.45
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Fig.　1　Typical periostin expression in human normal skin. Representative normal skin 
sections stained by immunohistochemistry with anti-periostin antibody. Periostin is ex-
pressed as a mild deposition at the epidermal-dermal junction (EDJ), papillary dermis, and 
around hair follicles. The staining is indicated by arrows. Asterisks show hair follicles (A). 
Magnifi cation, A:100×, B: 200×, C: 400×.
A
C
B
Since periostin null mice exhibit impaired collagen
cross-linking,12 it is hypothesized that periostin likely
affects lysyl oxidase (LOX), an enzyme involved in
cross-linking collagen that influences the mechanical
properties of connective tissues.46 Recently, Maru-
hashi et al. revealed that periostin enhanced LOX ac-
tivity; the levels of active LOX protein, formed by the
cleavage of its propeptide by bone morphogenetic
protein-1 (BMP-1), were decreased in periostin null
mice.47 Moreover, the overexpression of periostin
promoted the proteolytic cleavage of the propeptide
mediated by BMP-1, which binds to periostin.47 Thus,
periostin directly supported the BMP-1-mediated acti-
vation of LOX, accelerating collagen cross-linking and
maintaining the stiffness of connective tissues.
PERIOSTIN IN CUTANEOUS WOUND HEAL-
ING
Cutaneous wound healing is a series of physiological
events, which involves inflammation, reepithelializa-
tion, neovascularization, granulation tissue formation,
wound contraction, and ECM reorganization, in that
order.48,49 After tissue injury, the induction of pe-
riostin has been described in various tissues,20,50,51 in-
cluding the skin.32,33,36 In an experimental murine
dermal wound model, periostin upregulation was de-
tected first in the granulation tissue at day 3, followed
by a peak level at day 7, and returning to normal lev-
els by 28 days.32,33,36 Therefore, periostin is ex-
pressed not in the initial inflammatory stage of wound
repair but rather in the granulation and remodeling
stages.
Recently, three papers have been published exam-
ining the potential roles of periostin in excisional
dermal wound repair by analyzing periostin null
mice.34-36 Indeed, although the underlying mecha-
nisms proposed in these papers differed slightly,
similar results were observed all three reports, which
demonstrated delayed wound closure between days 3
and 7 in the knockout mice, suggesting consistent
and reproducible results. Nishiyama et al. proposed
that the delayed wound repair in the gene-deficient
model was due to defective reepithelialization and the
reduced proliferation of keratinocytes.34 Periostin-
overexpressing HaCaT cells were used to confirm
keratinocyte proliferation through phosphorylation of
the nuclear factor-κB (NF-κB), which is induced by
the proteolytic cleavage of laminin γ2 in association
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with periostin. Second, Elliot et al. confirmed a signifi-
cant reduction in the numbers of α-smooth muscle
actin (α-SMA)-positive myofibroblasts in the absence
of periostin in the granulation tissue.35 They pro-
posed that periostin promoted wound contraction by
facilitating the differentiation of myofibroblasts. Fi-
nally, based on in vitro analysis, Ontsuka et al.
showed that the loss of periostin resulted in defects
in fibroblasts differentiation and migration.36 Al-
though the mechanisms underlying the role of pe-
riostin in wound healing in vivo remain controversial,
partly because in vitro evidences may not always re-
flect in vivo phenomena52, the three reports clearly
revealed the crucial role of periostin in cutaneous
wound repair.34-36
In dermal wound repair, the proliferation and mi-
gration of keratinocytes are essential for skin reepi-
thelialization.48,49 Moreover, the activation and differ-
entiation of fibroblasts to myofibroblasts are also criti-
cal processes for appropriate skin contraction and re-
modeling.48,49 Recently, using different cell types and
experimental methodologies, in vitro studies have ex-
amined the actions of periostin on fibroblasts and
keratinocytes and their proliferation, migration, and
differentiation. As a matricellular protein, periostin in-
teracts with several integrin molecules, such as αvβ3
or αvβ5 on the cell surface, and activates phosphati-
dylinositol 3-kinase (PI3K)Akt, focal adhesion
kinase (FAK), and mitogen-activated protein (MAP)
kinases to exert its cellular functions.20,34,35,53-57 How-
ever, the molecular mechanism underlying the ac-
tions of periostin in the paracrine andor autocrine
loops, i.e., the epithelial-mesenchymal cross-talk
through periostin, remains poorly understood. A re-
cent study suggested the necessity of mammalian tar-
get of rapamycin (mTOR) signaling in periostin-
induced epithelial migration and proliferation,
wherein mTOR activation in epithelial cells was
shown to be induced not only by fibroblast-derived
periostin secreted during wound healing but also by
endogenously expressed periostin in epithelial cells
under mechanical stress.58 This result may provide a
clue in understanding the dynamic actions and ex-
pressions of periostin, both of the variant form as well
as the full-length form, since only a variant form of pe-
riostin can be secreted.
Using a three-dimensional organotypic air-liquid in-
terface co-culture system, Taniguchi et al. recently
demonstrated that periostin regulates keratinocyte
proliferation and differentiation in epithelial-mese-
nchymal interactions through a combination of an
autocrine loop of periostin and a paracrine loop com-
posed of IL-1α and IL-6.59 That is, the release of IL-1α
from keratinocytes and IL-6 production from fibro-
blasts were critical for keratinocyte proliferation and
differentiation. Fibroblast-derived periostin was re-
quired for IL-1α-induced IL-6 production, which oc-
curred via the activation of the NF-κB pathway. Thus,
accumulating evidence demonstrates the importance
of epithelial-mesenchymal cross-talk with periostin as
a key modulator in wound repair (Fig. 2). Applying
these findings to various skin-related pathologies is
expected to be of great interest.
PERIOSTIN IN SKIN-RELATED DISEASES
SKIN FIBROSIS
The excessive deposition of ECM components such
as collagen and fibronectin in tissues is defined as fi-
brosis.60 Organ fibrosis is a final common pathway for
many diseases and leads to end-stage organ failure.
Unfortunately, no effective therapy for organ fibrosis
is yet available. Uncontrollable wound healing re-
sponses, including acute and chronic inflammation,
angiogenesis, activation of resident cells, and abnor-
mal ECM remodeling, are thought to be involved in
the pathogenesis of fibrosis.60 TGF-β is regarded as a
major profibrotic factor, stimulating the synthesis of
ECM molecules and activating the differentiation of
fibroblasts to myofibroblasts.61,62
Significant periostin expression has been detected
during various tissue remodeling processes and in fi-
brotic conditions, including wound healing,9 hy-
pertrophic scar and keloid formation,33,63 myocardial
infarction,20 sub-epithelial fibrosis in bronchial ast-
hma,11 bone marrow fibrosis,23 pulmonary fibro-
sis,24,25 and systemic sclerosis.26,64 The previously
discussed functions of periostin, i.e., those promoting
collagen fibrillogenesis, collagen cross-linking, and
binding to other ECM proteins, essentially provide
tissue stiffness, which may contribute to fibrosis.
Moreover, the matricellular actions of periostin that
accelerate the proliferation and differentiation of fi-
broblasts to myofibroblasts also exacerbate fibrosis.
Therefore, periostin appears to be actively involved in
the pathogenic process of fibrosis, rather than merely
being a deposited ECM component in fibrous tissue
(Fig. 3).
SYSTEMIC SCLEROSIS
Systemic sclerosis (SSc) is a multisystem connective
tissue disease characterized by organ fibrosis particu-
larly in the skin and lungs, microvascular abnormali-
ties, and immune dysregulation.65 We and others
have reported the enhanced expression of periostin
in the skin of SSc patients.26,64 The clinically affected
skin of patients with diffuse cutaneous SSc showed
extremely intense deposition of periostin with uni-
form distribution throughout the dermis compared to
that in patients with limited cutaneous SSc. Maxi-
mum deposition was observed in the extracellular
area; moreover, periostin was also noted to be colo-
calized with fibroblasts, α-SMA-positive myofibro-
blasts, and endothelial cells. The critical involvement
of periostin in the pathogenesis of skin fibrosis in SSc
has been confirmed by Yang et al. using a bleomycin
(BLM)-induced skin fibrosis model.64,66 The dermal
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Fig.　2　Roles of periostin in wound healing. Wound healing requires reepithelial-
ization, granulation tissue formation, and wound contraction. Induced periostin 
modulates all of those steps by acting on keratinocytes and fi broblasts. Migrating 
and proliferating keratinocytes for the reepithelialization are shown as green. En-
dogenously expressed periostin and/or fi broblasts-derived periostin induce prolifer-
ation and/or migration of keratinocytes for the reepithelialization.58 The keratinocytes-
fi broblasts cross-talk in the presence of an autocrine loop of periostin regulates 
proliferation and differentiation of keratinocytes.59 Furthermore, periostin promotes 
differentiation of fi broblasts to myofi broblasts for the wound contraction.35 Finally, 
activated fi broblasts and myofi broblasts accelerate ECM production, resulting in 
fi brosis.
thickness did not initially differ between wild-type
mice (WT) and periostin null mice; however, follow-
ing BLM-induced skin fibrosis, the periostin null
mice showed significantly reduced dermal thickness
and collagen deposition, indicating a reduction in the
fibrotic process.
α-SMA-positive myofibroblasts, which persist in fi-
brotic connective tissue, are considered to be the fi-
nal effecter cell in all fibrotic conditions.67 Enhanced
myofibroblast deposition is a hallmark of fibrosis in
SSc. There is no doubt that TGF-β is a major inducer
of myofibroblast differentiation61,67; further, periostin
appears to promote this process.35 In fact, BLM-
induced myofibroblast deposition was reduced in pe-
riostin null mice.64 In addition, it is intriguing that
TGF-β-induced myofibroblast differentiation was at-
tenuated in periostin null fibroblasts in vitro. More-
over, although stimulation with periostin alone did
not induce α-SMA expression in WT fibroblasts in vi-
tro, TGF-β-induced α-SMA expression was enhanced
in the presence of periostin.64 Thus, it is likely that
periostin may act as a co-factor or as an enhancer of
TGF-β bioactivity. Akin to periostin, another matricel-
lular protein―connective tissue growth factor
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Fig.　3　The contribution of periostin to fi brosis. Fibrosis is caused as a result of chronic tissue 
injury and infl ammation. Rather than just being a structural ECM protein, periostin is involved in 
the pathogenic process of fi brosis. Periostin induces proliferation of keratinocytes and fi broblasts, 
contributes to epithelial-mesenchymal transition (EMT) of keratinocytes, and promotes differentiation 
of fi broblasts to myofi broblasts. In addition, periostin plays an important role as a co-factor of 
TGF-β to promote ECM production and differentiation to myofi broblasts. Furthermore, fundamental 
roles of periostin, i.e., those promoting collagen fi brillogenesis, collagen cross-linking, and binding 
to other ECM proteins, may contribute to fi brosis by providing tissue stiffness.
(CCN2)―has also been implicated in similar find-
ings. Rather than just being as a downstream media-
tor of TGF-β, CCN2 appears to be required for opti-
mal TGF-β fibrogenic function.68,69 Similarly, pe-
riostin may create a favorable environment for the ac-
tion of fibrogenic factors rather than being a principle
cause of fibrosis.
Recently, we reported a significant elevation of se-
rum periostin levels in patients with SSc.26 The levels
were considerably higher in the early stage of diffuse
cutaneous type SSc and were intensely correlated
with the severity of skin fibrosis, which was deter-
mined by the modified Rodnan total skin thickness
score.70 In terms of fibrosis, no clinically useful
biomarker relevant to disease activity has been estab-
lished. In particular, a biomarker of skin fibrosis with
minimal interobserver variability is needed. In addi-
tion, a previous similar study also showed increased
serum levels of periostin in patients with idiopathic
interstitial pneumonias (IIPs) and found that the lev-
els reflected histopathological classifications and pul-
monary function.24 Thus, serum periostin levels may
be a potential biomarker for fibroproliferative disor-
ders.
SKIN ALLERGIC INFLAMMATION: ATOPIC DER-
MATITIS
Tissue remodeling in allergic inflammation has been
implicated in various diseases, including bronchial
asthma,71,72 allergic rhinitis,29,73 eosinophilic esoph-
agitis,74 and atopic dermatitis.75,76 Recurring allergic
inflammation, which is predominantly associated with
Th2 cytokines such as IL-4IL-13, induces fibrosis be-
cause of continuous tissue repair and remodeling, re-
sulting in a clinically intractable condition.11 Discov-
ering the mechanisms underlying such remodeling in
order to modulate them may lead to novel therapeutic
strategies against chronic allergic inflammatory dis-
eases in the near future.
In recent years, the role of periostin in allergic in-
flammation has been highlighted.11,27-31 The POSTN
gene that encodes periostin was identified as a IL-4
IL-13 inducible gene by microarray analysis using hu-
man bronchial epithelial cells77; further, Takayama et
Function of Periostin in the Skin
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Fig.　4　A schematic model representing the pathogenic role of periostin in chronic 
AD infl ammation proposed by Masuoka et al..30
al. found that IL-4IL-13-induced periostin was a
novel component of subepithelial fibrosis, which is a
cardinal feature of bronchial asthma.11 As discussed
in the other review articles in this issue,38 it is note-
worthy that serum periostin levels appear to be a
novel potential clinical biomarker that can predict the
efficacy of lebrikizumab, a IL-13 monoclonal antibody,
in asthma patients with inadequately controlled dis-
ease despite inhaled glucocorticoid therapy.78
One of the most important skin-related allergic in-
flammatory diseases is atopic dermatitis (AD). AD is
a chronic inflammatory disorder characterized by ec-
zematous skin lesions with intolerable pruritus.79
Rubbing or scratching behavior due to pruritus is one
of the triggers of chronic skin lesions, especially of li-
chenification, which pathologically consists of epider-
mal acanthosis, chronic infiltration by inflammatory
cells, and fibrosis. Increased levels of IL-13 in licheni-
fied AD skin80 indicate the possible importance of IL-
13 in chronic inflammation and remodeling in AD.
Although the etiology of AD has not been fully ex-
plained thus far, recent studies have well character-
ized the pathogenesis of AD.81 A disruption of the
skin barrier, which is partly linked to loss-of-function
mutations in the gene encoding filaggrin,82 may allow
dermal penetration by external allergens, inducing al-
lergic inflammation. Several analyses using various
mouse models have revealed the importance of Th2
cytokines in AD.83 In addition, epithelial cell-derived
molecules, such as thymic stromal lymphopoietin
(TSLP), IL-25, and IL-33, are critical for enhancing
the Th2 response. Particularly, TSLP is a key mole-
cule linking keratinocytes with dendritic cells that in-
itiates Th2-polarized inflammation.84 However, the
underlying pathogenic mechanism for persistent
TSLP production in the chronic course of AD re-
mains unclear. In other words, the manner in which
immune and non-immune cells interact with each
other in mediating chronic inflammation in AD has
not been well understood. In this regard, Masuoka et
al. recently reported a pivotal pathogenic role of pe-
riostin in chronic allergic inflammation in AD.30 Accu-
mulating periostin in the dermis and an AD-like phe-
notype were observed in house dust mite extract
(HDM)-induced AD model mice in BALB-c as well as
C57BL6 mice, but not in Rag-2−−γc−− mice.30,31 How-
ever, genetically periostin-deficient mice exposed to
HDM had impaired Th2-induced inflammation and
lacked the morphological changes of AD, indicating
that periostin is critical for the induction of allergic
skin inflammation in this mice model. Furthermore,
they found that IL-4 and IL-13 stimulated fibroblasts
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to generate periostin, which acted on keratinocytes to
induce NF-κB activation via integrin αv, eventually re-
sulting in the production of proinflammatory cytoki-
nes such as TSLP. Consequently, these keratinocyte-
derived cytokines amplified the Th2-type immune re-
sponse, leading to further production of periostin.30
Hence, a vicious loop of Th2 and periostin maintains
persistent inflammation in AD (Fig. 4). Considering
these findings together, it is greatly intriguing that
the ECM protein “periostin” exhibits a prominent
role in a linked series of events at all levels, including
Th2 inflammation, keratinocyte activation, and possi-
bly skin remodeling (Fig. 2), in the chronic inflamma-
tion of AD. Notably, the inhibition of periostin or in-
tegrin αvβ3 prevented AD inflammation in their
mouse model.30 Thus, blocking the action of periostin
or periostin receptors is an attractive therapeutic
strategy for AD, although care should be taken re-
garding the possible risks of blocking periostin’s ac-
tions in tissue development, remodeling, and wound
healing.
Recently, we analyzed periostin levels in 257 adult
AD patients.85 Serum levels of periostin reflected dis-
ease severity; patients with the most severe type, i.e.,
“erythroderma,” had significantly elevated levels of
periostin. In addition, periostin was strongly accumu-
lated in the dermis of AD skin lesions with eryth-
roderma as well as lichenification. Furthermore, the
levels of thymus and activation-regulated chemokine
(TARC) and lactate dehydrogenase (LDH) as well as
eosinophil counts correlated with those of serum pe-
riostin; serial analysis showed a decrease in periostin
levels following treatment.85 These results indicate
the possibility of using periostin as a new biomarker
for AD.
Clinically, TARC has been shown to be an excellent
biomarker, with high correlations to the severity of
skin lesions expressed by SCORAD score.86 For
biomarkers, it is important to evaluate the clinical util-
ity of the molecule. With respect to periostin and
TARC, our preliminary study demonstrated that most
cases showing deviations between the levels of TARC
and periostin had concurrent viral or bacterial infec-
tion or an acute exacerbation of AD because of inap-
propriate treatment. This indicated that the levels of
periostin might not influenced by infections or by
acute events. Periostin levels may thus be a useful
novel chronic biomarker for AD, particularly when si-
multaneously evaluated with TARC. Further studies
are needed for evaluating the clinical significance of
periostin levels in AD.
CONCLUSIONS
In summary, the functions of periostin in the skin
may be divided into two major roles as follows: (i)
physiologically protective actions and (ii) pathogenic
contributions. Appropriate collagen assembly in the
skin requires periostin, and the enhancement of pe-
riostin expression under mechanical stress and injury
contributes to physiological ECM remodeling and
wound repair. On the other hand, as a result of aber-
rant ECM remodeling, periostin is pathogenically in-
volved in fibrosis-enhancing TGF-β activity. Further-
more, allergic conditions such as AD favor the pro-
duction of periostin, which maintains and amplifies
chronic allergic inflammation via fibroblast-kerati-
nocyte cross-talk. Periostin acts on cells either endo-
genously or exogenously in a paracrine or autocrine
manner. Further research on periostin for analyzing
the different characteristics of known periostin vari-
ants, may provide a new understanding of this mole-
cule and offer potential therapeutic strategies against
skin-related inflammatory diseases.
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